LGI1 AUTOIMMUNE ENCEPHALITIS

Clinical trials for LGI1 AUTOIMMUNE ENCEPHALITIS explained in plain language.

Never miss a new study

Get alerted when new LGI1 AUTOIMMUNE ENCEPHALITIS trials appear

Sign up with your email to follow new studies for LGI1 AUTOIMMUNE ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets rare 'Brain on Fire' diseases

Disease control Recruiting now

This study is testing an investigational drug called satralizumab for people with two rare autoimmune brain diseases (NMDAR or LGI1 encephalitis). The goal is to see if the drug helps improve patients' daily function and reduces seizures better than a placebo, while monitoring sa…

Matched conditions: LGI1 AUTOIMMUNE ENCEPHALITIS

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

LGI1 AUTOIMMUNE ENCEPHALITIS

Get alerted when new LGI1 AUTOIMMUNE ENCEPHALITIS trials appear

New drug trial targets rare 'Brain on Fire' diseases